Is APUS or APVO more undervalued in 2026?

CirclFi compares Apimeds Pharmaceuticals US, Inc (APUS) and Aptevo Therapeutics Inc. (APVO) using 13 institutional-grade valuation models. APUS has a Quality of Company score of 4.8/10 while APVO scores 4.2/10.

Which is a better buy — APUS or APVO?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do APUS and APVO valuations compare?

APUS at $1.41 and APVO at $4.91 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

APUS vs APVO Valuation Comparison 2026 — Intrinsic Value Analysis

APUS

Pharmaceutical Preparations

Apimeds Pharmaceuticals US, Inc

Quality

4.8

out of 10

Value Trap

SAFE

Price

$1.41

Last close

Models

7/13

Active

APVO

Pharmaceutical Preparations

Aptevo Therapeutics Inc.

Quality

4.2

out of 10

Value Trap

SAFE

Price

$4.91

Last close

Models

6/13

Active

Model-by-Model Comparison

Model	Type	APUS Fair Value	APUS Upside	APVO Fair Value	APVO Upside
Bayesian DCF	Intrinsic	$0.41	-70.8%	$6.09	+24.1%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$6.62	+369.5%	$0.36	-92.6%
Dynamic NAV	Asset-Based	$4.65	+230.1%	—	—
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for APUS vs APVO — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

APUS vs APVO — Which Stock Is More Undervalued?

APUS scores higher with a 4.8/10 quality rating vs APVO's 4.2/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Apimeds Pharmaceuticals US, Inc (APUS) and Aptevo Therapeutics Inc. (APVO) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

APUS currently trades at $1.41 with a QOC of 4.8/10, while APVO trades at $4.91 with a QOC of 4.2/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).